Clinical Management of Asthma by Respiratory Specialists versus General Practitioners: Questionnaire Survey Results Over 6 Years.
adherence
asthma control test
bronchial asthma
general practitioners
questionnaire
Journal
International journal of general medicine
ISSN: 1178-7074
Titre abrégé: Int J Gen Med
Pays: New Zealand
ID NLM: 101515487
Informations de publication
Date de publication:
2021
2021
Historique:
received:
14
11
2020
accepted:
22
02
2021
entrez:
1
4
2021
pubmed:
2
4
2021
medline:
2
4
2021
Statut:
epublish
Résumé
In Japan, the Ministry of Health, Labour and Welfare population dynamics investigation showed a decrease in the number of deaths related to asthma in recent years. In 2016, the mortality rate was 1.2 deaths per 100,000 population. There were regional differences; Shimane Prefecture had a higher mortality rate (1.6 deaths per 100,000 population in 2016) than other prefectures. In this study, to clarify problems in asthma treatment, we evaluated the status of asthma treatment in Shimane Prefecture. We performed three cross-sectional questionnaire surveys, in October 2006, February 2009, and February 2012. We received responses from 78 clinics and hospitals. Subjects were patients with bronchial asthma over 14 years of age who regularly visited an outpatient clinic. Survey items included smoking status, control status assessed using the Asthma Control Test (ACT), treatment, and medication adherence. Doctors board-certified by the Japanese Respiratory Society were defined as respiratory specialists (RSs) and other doctors were defined as general practitioners (GPs). We compared various factors between the RS and GP groups. Clinical data of 2159 patients were available for analysis. The proportion of patients with ACT score ≥ 20 points increased significantly between 2006 and 2012 in the GP group. The rate of inhaled corticosteroid use increased in the GP group from 63.6% to 76.4%. It was suggested that asthma control and the rate of inhaled corticosteroid use were related. We should continue educating GPs about asthma treatment.
Sections du résumé
BACKGROUND
BACKGROUND
In Japan, the Ministry of Health, Labour and Welfare population dynamics investigation showed a decrease in the number of deaths related to asthma in recent years. In 2016, the mortality rate was 1.2 deaths per 100,000 population. There were regional differences; Shimane Prefecture had a higher mortality rate (1.6 deaths per 100,000 population in 2016) than other prefectures. In this study, to clarify problems in asthma treatment, we evaluated the status of asthma treatment in Shimane Prefecture.
METHODS
METHODS
We performed three cross-sectional questionnaire surveys, in October 2006, February 2009, and February 2012. We received responses from 78 clinics and hospitals. Subjects were patients with bronchial asthma over 14 years of age who regularly visited an outpatient clinic. Survey items included smoking status, control status assessed using the Asthma Control Test (ACT), treatment, and medication adherence. Doctors board-certified by the Japanese Respiratory Society were defined as respiratory specialists (RSs) and other doctors were defined as general practitioners (GPs). We compared various factors between the RS and GP groups.
RESULTS
RESULTS
Clinical data of 2159 patients were available for analysis. The proportion of patients with ACT score ≥ 20 points increased significantly between 2006 and 2012 in the GP group. The rate of inhaled corticosteroid use increased in the GP group from 63.6% to 76.4%.
CONCLUSION
CONCLUSIONS
It was suggested that asthma control and the rate of inhaled corticosteroid use were related. We should continue educating GPs about asthma treatment.
Identifiants
pubmed: 33790629
doi: 10.2147/IJGM.S292188
pii: 292188
pmc: PMC8005259
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1003-1011Informations de copyright
© 2021 Hamaguchi et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest related to this work.
Références
J Allergy Clin Immunol. 2004 Jan;113(1):59-65
pubmed: 14713908
N Engl J Med. 2012 Sep 27;367(13):1198-207
pubmed: 22938706
Am J Respir Crit Care Med. 1997 Apr;155(4):1235-40
pubmed: 9105060
J Asthma. 2015 Mar;52(2):162-9
pubmed: 25105556
Allergol Int. 2016 Oct;65(4):444-449
pubmed: 27155752
Respir Med. 2011 Jun;105(6):930-8
pubmed: 21367593
JAMA. 1992 Dec 23-30;268(24):3462-4
pubmed: 1460737
J Eval Clin Pract. 2013 Apr;19(2):223-9
pubmed: 21689218
J Allergy Clin Immunol. 2004 Dec;114(6):1288-93
pubmed: 15577825
N Engl J Med. 2011 May 5;364(18):1695-707
pubmed: 21542741
Arerugi. 2014 Jun;63(6):794-804
pubmed: 24953739
N Engl J Med. 2010 Oct 28;363(18):1715-26
pubmed: 20979471
Respir Med. 2007 Sep;101(9):1895-902
pubmed: 17587559
J Allergy Clin Immunol. 2003 Jul;112(1):29-36
pubmed: 12847476
Clin Exp Allergy. 2002 Aug;32(8):1180-6
pubmed: 12190656
Thorax. 2000 Jan;55(1):19-24
pubmed: 10607797